Piperlongumine induces rapid depletion of the androgen receptor in human prostate cancer cells

Targeting Continued Androgen Receptor Signaling in Prostate Cancer

(2011) C. Massard et al.   CLINICAL CANCER RESEARCH

Abiraterone and MVD3100 Take Androgen Deprivation to a New Level

(2011) C. Schmidt   JNCI-Journal of the National Cancer Institute

Berberine Suppresses Androgen Receptor Signaling in Prostate Cancer

(2011) J. Li et al.   MOLECULAR CANCER THERAPEUTICS

Selective killing of cancer cells by a small molecule targeting the stress response to ROS

(2011) Lakshmi Raj et al.   NATURE

Acute toxicity of berberine and its correlation with the blood concentration in mice

(2010) Michael M. Kheir et al.   FOOD AND CHEMICAL TOXICOLOGY

Biology and natural history of prostate cancer and the role of chemoprevention

(2010) M. T. Rosenberg et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

Cancer Prevention: From 1727 to Milestones of the Past 100 Years

(2009) Scott M. Lippman et al.   CANCER RESEARCH

Anti-androgens and androgen-depleting therapies in prostate cancer: new agents for an established target

(2009) Yu Chen et al.   LANCET ONCOLOGY

Maintenance of Intratumoral Androgens in Metastatic Prostate Cancer: A Mechanism for Castration-Resistant Tumor Growth

(2008) R. B. Montgomery et al.   CANCER RESEARCH

Ligand-Independent Androgen Receptor Variants Derived from Splicing of Cryptic Exons Signify Hormone-Refractory Prostate Cancer

(2008) R. Hu et al.   CANCER RESEARCH

Zinc chelation induces rapid depletion of the X-linked inhibitor of apoptosis and sensitizes prostate cancer cells to TRAIL-mediated apoptosis

(2008) P Makhov et al.   CELL DEATH AND DIFFERENTIATION

Overexpression of the Zinc Uptake Transporter hZIP1 Inhibits Nuclear Factor- B and Reduces the Malignant Potential of Prostate Cancer Cells In vitro and In vivo

(2008) K. Golovine et al.   CLINICAL CANCER RESEARCH

Optimizing treatment for men with advanced prostate cancer: Expert recommendations and the multidisciplinary approach

(2008) John M. Fitzpatrick et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

Isosilybin B causes androgen receptor degradation in human prostate carcinoma cells via PI3K-Akt-Mdm2-mediated pathway

(2008) G Deep et al.   ONCOGENE

Mechanisms of Berberine (Natural Yellow 18)–Induced Mitochondrial Dysfunction: Interaction with the Adenine Nucleotide Translocator

(2008) Cláudia V. Pereira et al.   TOXICOLOGICAL SCIENCES

In vivogrowth inhibition of sarcoma 180 by piperlonguminine, an alkaloid amide from thePiperspecies

(2007) Daniel P. Bezerra et al.   JOURNAL OF APPLIED TOXICOLOGY